Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)
A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compound...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2023-04, Vol.252, p.115304-115304, Article 115304 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 115304 |
---|---|
container_issue | |
container_start_page | 115304 |
container_title | European journal of medicinal chemistry |
container_volume | 252 |
creator | Ivasechko, Iryna Lozynskyi, Andrii Senkiv, Julia Roszczenko, Piotr Kozak, Yuliia Finiuk, Nataliya Klyuchivska, Olga Kashchak, Nataliya Manko, Nazar Maslyak, Zvenyslava Lesyk, Danylo Karkhut, Andriy Polovkovych, Svyatoslav Czarnomysy, Robert Szewczyk, Olga Kozytskiy, Andriy Karpenko, Olexandr Khyluk, Dmytro Gzella, Andrzej Bielawski, Krzysztof Bielawska, Anna Dzubak, Petr Gurska, Sona Hajduch, Marian Stoika, Rostyslav Lesyk, Roman |
description | A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo.
[Display omitted]
•Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice. |
doi_str_mv | 10.1016/j.ejmech.2023.115304 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2793989256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523423002702</els_id><sourcerecordid>2793989256</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</originalsourceid><addsrcrecordid>eNp9UcuKFTEQDaI419E_EMlyhJtrXv3aCMPgC0bc6EokpJPq6TR9k2uSHm33_rcZenTpoqiiOFWn6hyEnjN6YJTVr6YDTEcw44FTLg6MVYLKB2jHmrolglfyIdpRzgWpuJBn6ElKE6W0qil9jM5EQykTHd2h3x_DDGaZdcQWkrvxe5xWn8dSJ6y9LZGd0d5AxNpkd-vyisOAPfzAeXThtEbtw1e-F8R-Kw39q-xLuNcJLA4eV2RcbQw_V8L2knh9GvMYvi_OBw_4Ylpu5lK8fIoeDXpO8Ow-n6Mvb998vnpPrj-9-3B1eU2MpG0m1gBvW86gYrIxsoGOMT40tdRV12gwhnWDbpk1si968LZntK-F1FR0IIa2FefoYtt7iuUISFkdXTIwz9pDWJLiTSe6tuNVXaByg5oYUoowqFN0Rx1Xxai6M0BNajNA3RmgNgPK2It7hqU_gv039FfxAni9AaD8eesgqmQcFH2ti2CyssH9n-EPmwOZZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2793989256</pqid></control><display><type>article</type><title>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ivasechko, Iryna ; Lozynskyi, Andrii ; Senkiv, Julia ; Roszczenko, Piotr ; Kozak, Yuliia ; Finiuk, Nataliya ; Klyuchivska, Olga ; Kashchak, Nataliya ; Manko, Nazar ; Maslyak, Zvenyslava ; Lesyk, Danylo ; Karkhut, Andriy ; Polovkovych, Svyatoslav ; Czarnomysy, Robert ; Szewczyk, Olga ; Kozytskiy, Andriy ; Karpenko, Olexandr ; Khyluk, Dmytro ; Gzella, Andrzej ; Bielawski, Krzysztof ; Bielawska, Anna ; Dzubak, Petr ; Gurska, Sona ; Hajduch, Marian ; Stoika, Rostyslav ; Lesyk, Roman</creator><creatorcontrib>Ivasechko, Iryna ; Lozynskyi, Andrii ; Senkiv, Julia ; Roszczenko, Piotr ; Kozak, Yuliia ; Finiuk, Nataliya ; Klyuchivska, Olga ; Kashchak, Nataliya ; Manko, Nazar ; Maslyak, Zvenyslava ; Lesyk, Danylo ; Karkhut, Andriy ; Polovkovych, Svyatoslav ; Czarnomysy, Robert ; Szewczyk, Olga ; Kozytskiy, Andriy ; Karpenko, Olexandr ; Khyluk, Dmytro ; Gzella, Andrzej ; Bielawski, Krzysztof ; Bielawska, Anna ; Dzubak, Petr ; Gurska, Sona ; Hajduch, Marian ; Stoika, Rostyslav ; Lesyk, Roman</creatorcontrib><description>A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo.
[Display omitted]
•Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2023.115304</identifier><identifier>PMID: 37001390</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Anticancer activity ; Antineoplastic Agents - chemistry ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; DNA interaction ; Doxorubicin - pharmacology ; Drug design ; Drug Screening Assays, Antitumor ; Humans ; Juglone ; Mice ; Molecular docking ; Molecular Docking Simulation ; Molecular Structure ; Naphthoquinones - pharmacology ; Structure-Activity Relationship ; Thiazoles - chemistry ; Thiopyranothiazoles</subject><ispartof>European journal of medicinal chemistry, 2023-04, Vol.252, p.115304-115304, Article 115304</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</citedby><cites>FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</cites><orcidid>0000-0002-3322-0080</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2023.115304$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37001390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivasechko, Iryna</creatorcontrib><creatorcontrib>Lozynskyi, Andrii</creatorcontrib><creatorcontrib>Senkiv, Julia</creatorcontrib><creatorcontrib>Roszczenko, Piotr</creatorcontrib><creatorcontrib>Kozak, Yuliia</creatorcontrib><creatorcontrib>Finiuk, Nataliya</creatorcontrib><creatorcontrib>Klyuchivska, Olga</creatorcontrib><creatorcontrib>Kashchak, Nataliya</creatorcontrib><creatorcontrib>Manko, Nazar</creatorcontrib><creatorcontrib>Maslyak, Zvenyslava</creatorcontrib><creatorcontrib>Lesyk, Danylo</creatorcontrib><creatorcontrib>Karkhut, Andriy</creatorcontrib><creatorcontrib>Polovkovych, Svyatoslav</creatorcontrib><creatorcontrib>Czarnomysy, Robert</creatorcontrib><creatorcontrib>Szewczyk, Olga</creatorcontrib><creatorcontrib>Kozytskiy, Andriy</creatorcontrib><creatorcontrib>Karpenko, Olexandr</creatorcontrib><creatorcontrib>Khyluk, Dmytro</creatorcontrib><creatorcontrib>Gzella, Andrzej</creatorcontrib><creatorcontrib>Bielawski, Krzysztof</creatorcontrib><creatorcontrib>Bielawska, Anna</creatorcontrib><creatorcontrib>Dzubak, Petr</creatorcontrib><creatorcontrib>Gurska, Sona</creatorcontrib><creatorcontrib>Hajduch, Marian</creatorcontrib><creatorcontrib>Stoika, Rostyslav</creatorcontrib><creatorcontrib>Lesyk, Roman</creatorcontrib><title>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo.
[Display omitted]
•Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.</description><subject>Animals</subject><subject>Anticancer activity</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Apoptosis</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>DNA interaction</subject><subject>Doxorubicin - pharmacology</subject><subject>Drug design</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Juglone</subject><subject>Mice</subject><subject>Molecular docking</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Structure</subject><subject>Naphthoquinones - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Thiazoles - chemistry</subject><subject>Thiopyranothiazoles</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcuKFTEQDaI419E_EMlyhJtrXv3aCMPgC0bc6EokpJPq6TR9k2uSHm33_rcZenTpoqiiOFWn6hyEnjN6YJTVr6YDTEcw44FTLg6MVYLKB2jHmrolglfyIdpRzgWpuJBn6ElKE6W0qil9jM5EQykTHd2h3x_DDGaZdcQWkrvxe5xWn8dSJ6y9LZGd0d5AxNpkd-vyisOAPfzAeXThtEbtw1e-F8R-Kw39q-xLuNcJLA4eV2RcbQw_V8L2knh9GvMYvi_OBw_4Ylpu5lK8fIoeDXpO8Ow-n6Mvb998vnpPrj-9-3B1eU2MpG0m1gBvW86gYrIxsoGOMT40tdRV12gwhnWDbpk1si968LZntK-F1FR0IIa2FefoYtt7iuUISFkdXTIwz9pDWJLiTSe6tuNVXaByg5oYUoowqFN0Rx1Xxai6M0BNajNA3RmgNgPK2It7hqU_gv039FfxAni9AaD8eesgqmQcFH2ti2CyssH9n-EPmwOZZg</recordid><startdate>20230405</startdate><enddate>20230405</enddate><creator>Ivasechko, Iryna</creator><creator>Lozynskyi, Andrii</creator><creator>Senkiv, Julia</creator><creator>Roszczenko, Piotr</creator><creator>Kozak, Yuliia</creator><creator>Finiuk, Nataliya</creator><creator>Klyuchivska, Olga</creator><creator>Kashchak, Nataliya</creator><creator>Manko, Nazar</creator><creator>Maslyak, Zvenyslava</creator><creator>Lesyk, Danylo</creator><creator>Karkhut, Andriy</creator><creator>Polovkovych, Svyatoslav</creator><creator>Czarnomysy, Robert</creator><creator>Szewczyk, Olga</creator><creator>Kozytskiy, Andriy</creator><creator>Karpenko, Olexandr</creator><creator>Khyluk, Dmytro</creator><creator>Gzella, Andrzej</creator><creator>Bielawski, Krzysztof</creator><creator>Bielawska, Anna</creator><creator>Dzubak, Petr</creator><creator>Gurska, Sona</creator><creator>Hajduch, Marian</creator><creator>Stoika, Rostyslav</creator><creator>Lesyk, Roman</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3322-0080</orcidid></search><sort><creationdate>20230405</creationdate><title>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</title><author>Ivasechko, Iryna ; Lozynskyi, Andrii ; Senkiv, Julia ; Roszczenko, Piotr ; Kozak, Yuliia ; Finiuk, Nataliya ; Klyuchivska, Olga ; Kashchak, Nataliya ; Manko, Nazar ; Maslyak, Zvenyslava ; Lesyk, Danylo ; Karkhut, Andriy ; Polovkovych, Svyatoslav ; Czarnomysy, Robert ; Szewczyk, Olga ; Kozytskiy, Andriy ; Karpenko, Olexandr ; Khyluk, Dmytro ; Gzella, Andrzej ; Bielawski, Krzysztof ; Bielawska, Anna ; Dzubak, Petr ; Gurska, Sona ; Hajduch, Marian ; Stoika, Rostyslav ; Lesyk, Roman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Anticancer activity</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Apoptosis</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>DNA interaction</topic><topic>Doxorubicin - pharmacology</topic><topic>Drug design</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Juglone</topic><topic>Mice</topic><topic>Molecular docking</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Structure</topic><topic>Naphthoquinones - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Thiazoles - chemistry</topic><topic>Thiopyranothiazoles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivasechko, Iryna</creatorcontrib><creatorcontrib>Lozynskyi, Andrii</creatorcontrib><creatorcontrib>Senkiv, Julia</creatorcontrib><creatorcontrib>Roszczenko, Piotr</creatorcontrib><creatorcontrib>Kozak, Yuliia</creatorcontrib><creatorcontrib>Finiuk, Nataliya</creatorcontrib><creatorcontrib>Klyuchivska, Olga</creatorcontrib><creatorcontrib>Kashchak, Nataliya</creatorcontrib><creatorcontrib>Manko, Nazar</creatorcontrib><creatorcontrib>Maslyak, Zvenyslava</creatorcontrib><creatorcontrib>Lesyk, Danylo</creatorcontrib><creatorcontrib>Karkhut, Andriy</creatorcontrib><creatorcontrib>Polovkovych, Svyatoslav</creatorcontrib><creatorcontrib>Czarnomysy, Robert</creatorcontrib><creatorcontrib>Szewczyk, Olga</creatorcontrib><creatorcontrib>Kozytskiy, Andriy</creatorcontrib><creatorcontrib>Karpenko, Olexandr</creatorcontrib><creatorcontrib>Khyluk, Dmytro</creatorcontrib><creatorcontrib>Gzella, Andrzej</creatorcontrib><creatorcontrib>Bielawski, Krzysztof</creatorcontrib><creatorcontrib>Bielawska, Anna</creatorcontrib><creatorcontrib>Dzubak, Petr</creatorcontrib><creatorcontrib>Gurska, Sona</creatorcontrib><creatorcontrib>Hajduch, Marian</creatorcontrib><creatorcontrib>Stoika, Rostyslav</creatorcontrib><creatorcontrib>Lesyk, Roman</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivasechko, Iryna</au><au>Lozynskyi, Andrii</au><au>Senkiv, Julia</au><au>Roszczenko, Piotr</au><au>Kozak, Yuliia</au><au>Finiuk, Nataliya</au><au>Klyuchivska, Olga</au><au>Kashchak, Nataliya</au><au>Manko, Nazar</au><au>Maslyak, Zvenyslava</au><au>Lesyk, Danylo</au><au>Karkhut, Andriy</au><au>Polovkovych, Svyatoslav</au><au>Czarnomysy, Robert</au><au>Szewczyk, Olga</au><au>Kozytskiy, Andriy</au><au>Karpenko, Olexandr</au><au>Khyluk, Dmytro</au><au>Gzella, Andrzej</au><au>Bielawski, Krzysztof</au><au>Bielawska, Anna</au><au>Dzubak, Petr</au><au>Gurska, Sona</au><au>Hajduch, Marian</au><au>Stoika, Rostyslav</au><au>Lesyk, Roman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2023-04-05</date><risdate>2023</risdate><volume>252</volume><spage>115304</spage><epage>115304</epage><pages>115304-115304</pages><artnum>115304</artnum><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo.
[Display omitted]
•Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>37001390</pmid><doi>10.1016/j.ejmech.2023.115304</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-3322-0080</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2023-04, Vol.252, p.115304-115304, Article 115304 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_2793989256 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Anticancer activity Antineoplastic Agents - chemistry Apoptosis Cell Line, Tumor Cell Proliferation DNA interaction Doxorubicin - pharmacology Drug design Drug Screening Assays, Antitumor Humans Juglone Mice Molecular docking Molecular Docking Simulation Molecular Structure Naphthoquinones - pharmacology Structure-Activity Relationship Thiazoles - chemistry Thiopyranothiazoles |
title | Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T06%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20design,%20synthesis%20and%20anticancer%20activity%20of%20new%20thiopyrano%5B2,3-d%5Dthiazoles%20based%20on%205-hydroxy-1,4-naphthoquinone%20(juglone)&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Ivasechko,%20Iryna&rft.date=2023-04-05&rft.volume=252&rft.spage=115304&rft.epage=115304&rft.pages=115304-115304&rft.artnum=115304&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2023.115304&rft_dat=%3Cproquest_cross%3E2793989256%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2793989256&rft_id=info:pmid/37001390&rft_els_id=S0223523423002702&rfr_iscdi=true |